In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus

In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus

G-protein coupled receptor 119 (GPR119) has emerged as a promising new target for the treatment of type 2 diabetes mellitus. The expression of GPR119 on the pancreatic B cells and intestinal L cells provides a unique opportunity for a single drug to promote insulin and GLP-1 secretion. In this study...

Full description

Bibliographic Details
Main Authors: Kim, So Ra, Kim, Dae-Hoon, Park, Soo Hyun, Kim, Young Seok, Kim, Chun Hwa, Ha, Tae-Young, Yang, Jin, Rhee, Jae-Keol
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872231/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872231/

Similar Items